{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:00Z","timestamp":1790312400609,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endothelial-to-mesenchymal transition (EndMT) and vasculogenic mimicry (VM) are distinct forms of cellular and vascular plasticity that may contribute to tumor vascular adaptation. Although they have largely evolved as separate research fields, emerging experimental observations suggest potential convergence in their regulation by the tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a comparative bibliometric analysis of EndMT and VM using the Web of Science Core Collection and Scopus for publications from 2005 to 2025. After cross-database deduplication and retraction screening using a custom open-source data-fusion pipeline, 4,746 records were retained (2,056 EndMT; 2,695 VM).Publication trends, collaboration networks, keyword co-occurrence, thematic structures, and citation bursts were analyzed using bibliometrix\/Biblioshiny, VOSviewer, and CiteSpace.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only five publications explicitly addressed both EndMT and VM in an oncological context, indicating limited formal overlap between the two literatures. Nevertheless, keyword co-occurrence, citation-burst, and thematic analyses revealed convergent research interests involving the tumor microenvironment, cellular plasticity, extracellular-matrix remodeling, and therapeutic resistance. These patterns motivated a mechanistic synthesis centered on three potential points of convergence: shared upstream signaling involving TGF-\u03b2, hypoxia\/HIF-1\u03b1, and context-dependent Notch activity; EndMT-associated stromal and extracellular-matrix remodeling that may facilitate VM; and partial or hybrid cellular states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      EndMT and VM should be considered distinct but potentially interconnected components of tumor vascular plasticity rather than simple alternatives to conventional angiogenesis. The bibliometric convergence provides a rationale for investigating their potential interactions, but does not establish a causal or bidirectional relationship. We therefore propose a testable conceptual framework in which shared microenvironmental pressures may influence both processes, while EndMT-associated stromal remodeling may provide one potential route toward a VM-permissive niche. Spatial transcriptomics, lineage tracing, co-culture models, and organoid systems may help determine whether these interactions occur\n                      <jats:italic>in vivo<\/jats:italic>\n                      and whether reciprocal regulation exists.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1944544","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:10Z","timestamp":1790310430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial-to-mesenchymal transition and vasculogenic mimicry in tumor vascular plasticity: a comparative bibliometric analysis and mechanistic framework"],"prefix":"10.3389","volume":"16","author":[{"given":"Congcheng","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]},{"name":"The Fourth Affiliated Hospital, China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiduo","family":"Fang","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Shenyang Medical College","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Radiation Oncology, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cytogfr.2025.10.002","article-title":"Arteriolar angiogenesis: implications in anti-angiogenic immunotherapy for pancreatic cancers","volume":"86","author":"Beck","year":"2025","journal-title":"Cytokine Growth Fact Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-032222-080806","article-title":"Endothelial to mesenchymal transition in health and disease","volume":"85","author":"Xu","year":"2023","journal-title":"Annu Rev Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","article-title":"Vasculogenic mimicry in carcinogenesis and clinical applications","volume":"13","author":"Luo","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transd Targ Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00221","article-title":"Resistance mechanisms to anti-angiogenic therapies in cancer","volume":"10","author":"Haibe","year":"2020","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biology14101403","article-title":"Cancer-associated fibroblasts arising from endothelial-to-mesenchymal transition: induction factors, functional roles, and transcriptomic evidence","volume":"14","author":"Han","year":"2025","journal-title":"Biology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143433","article-title":"The anti-VEGF(R) drug discovery legacy: improving attrition rates by breaking the vicious cycle of angiogenesis in cancer","volume":"13","author":"Ribatti","year":"2021","journal-title":"Cancers"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist Updates: Rev Commentaries Antimicrob Anticancer Chemother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70313","article-title":"Angiogenesis and targeted therapy in the tumour microenvironment: from basic to clinical practice","volume":"15","author":"Yang","year":"2025","journal-title":"Clin Transl Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-9966-31-16","article-title":"Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis","volume":"31","author":"Xu","year":"2012","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-207","article-title":"Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40118","article-title":"Endothelial-to-mesenchymal transition in the tumor microenvironment: roles of transforming growth factor-\u03b2 and matrix metalloproteins","volume":"10","author":"Du","year":"2024","journal-title":"Heliyon"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0439-4","article-title":"Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage","volume":"52","author":"Choi","year":"2020","journal-title":"Exp Mol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115029","article-title":"The driving mechanism and targeting value of mimicry between vascular endothelial cells and tumor cells in tumor progression","volume":"165","author":"Ma","year":"2023","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813770","article-title":"Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets","volume":"15","author":"Tang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1481726","article-title":"Vasculogenic mimicry in non-small cell lung cancer: a systematic review","volume":"15","author":"Shapkina","year":"2025","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10456-016-9500-2","article-title":"Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis","volume":"19","author":"Yang","year":"2016","journal-title":"Angiogenesis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.07.148","article-title":"Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis","volume":"49","author":"Cao","year":"2013","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1186\/s12885-024-12903-5","article-title":"Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702021","article-title":"Regulation of partial and reversible endothelial-to-mesenchymal transition in angiogenesis","volume":"9","author":"Fang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116180","article-title":"Endothelial-to-mesenchymal transition in cardiovascular pathophysiology","volume":"25","author":"Singh","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00260","article-title":"TGF-\u03b2-induced endothelial to mesenchymal transition in disease and tissue engineering","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2016.09.012","article-title":"Vascular mimicry formation is promoted by paracrine TGF-\u03b2 and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma","volume":"383","author":"Yang","year":"2016","journal-title":"Cancer Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202307.1203.v1","article-title":"The inhibition of the FGFR\/PI3K\/Akt axis by AZD4547 disrupts the proangiogenic microenvironment and vasculogenic mimicry arising from the interplay between endothelial and triple-negative breast cancer cells","volume":"24","author":"Morales-Guadarrama","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.107045","article-title":"What is the impact of endothelial-to-mesenchymal transition in solid tumours: a qualitative systematic review and quantitative meta-analysis","volume":"21","author":"Hern\u00e1ndez-Camarero","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.616610","article-title":"TGF-\u03b2-induced endothelial to mesenchymal transition is determined by a balance between SNAIL and ID factors","volume":"9","author":"Ma","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13072-025-00649-8","article-title":"Research advances in epigenetic modifications and post-translational modifications in endothelial-mesenchymal transition","volume":"18","author":"Shen","year":"2025","journal-title":"Epigenet Chromatin"},{"key":"B34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/circresaha.115.303883","article-title":"Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-like factor 4 promoter in vitro and in vivo","volume":"115","author":"Jiang","year":"2014","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2025.0048","article-title":"Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance","volume":"22","author":"Serrat\u00ec","year":"2025","journal-title":"Cancer Biol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119343","article-title":"VE-cadherin in cancer-associated angiogenesis: a deceptive strategy of blood vessel formation","volume":"24","author":"Delgado-Bellido","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136353","article-title":"Shifting shapes: the endothelial-to-mesenchymal transition as a driver for cancer progression","volume":"26","author":"Giordanengo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010211","article-title":"Cancer-associated fibroblasts: major co-conspirators in tumor development","volume":"16","author":"Singh","year":"2024","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12079-022-00693-z","article-title":"Lupeol and paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1\u03b1-EphA2-laminin-5\u03b32 network in human oral cancer","volume":"17","author":"Saha","year":"2023","journal-title":"J Cell Commun Signaling"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0245-5","article-title":"Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2","volume":"29","author":"Zhao","year":"2012","journal-title":"Med Oncol (Northwood London England)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.03.025","article-title":"The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis","volume":"137","author":"Benedito","year":"2009","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cas.16045","article-title":"CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment","volume":"115","author":"Takahashi","year":"2024","journal-title":"Cancer Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-1616","article-title":"Tumor endothelial cells with distinct patterns of TGF\u03b2-driven endothelial-to-mesenchymal transition","volume":"75","author":"Xiao","year":"2015","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1719076115","article-title":"Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features","volume":"115","author":"Arandkar","year":"2018","journal-title":"PNAS"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1089068","article-title":"Cancer-associated fibroblasts: the chief architect in the tumor microenvironment","volume":"11","author":"Sarkar","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.553342","article-title":"NFATc acts as a non-canonical phenotypic stability factor for a hybrid epithelial\/mesenchymal phenotype","volume":"10","author":"Subbalakshmi","year":"2020","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22257","article-title":"A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in Malignancies","volume":"85","author":"Zhao","year":"2024","journal-title":"Drug Dev Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m115.636944","article-title":"Snail is a direct target of hypoxia-inducible factor 1\u03b1 (HIF1\u03b1) in hypoxia-induced endothelial to mesenchymal transition of human coronary endothelial cells","volume":"290","author":"Xu","year":"2015","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1944544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:11Z","timestamp":1790310431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1944544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":52,"alternative-id":["10.3389\/fonc.2026.1944544"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1944544","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1944544"}}